schedule a meeting with our team
Schedule some time to discuss your ongoing or future projects with our FHI Clinical team members who will be in attendance at the ASTMH 2020 Annual Meeting.
Schedule some time to discuss your ongoing or future projects with our FHI Clinical team members who will be in attendance at the ASTMH 2020 Annual Meeting.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA
As Senior Vice President, Clinical Operations, Claudia Christian leads the overall direction and strategic implementation of program execution for all clinical research activities at FHI Clinical, ensuring that high quality services are delivered on time and within scope and budget.
In her previous role as Director of Global Clinical Operations for FHI 360’s Global Research Services (GRS), Christian provided strategic direction for the organization’s clinical programs, ensuring compliance with policies and procedures as well as regulatory authority requirements and guidelines.
Christian has worked in clinical research across multiple indications for more than 25 years. She previously served as Vice President, Global Operations at ClinicalRM, and as Director Strategic Partnerships at PAREXEL. She has held multiple positions in pharmaceutical, biotech and CRO industries.
Christian holds a bachelor’s degree in Biology from Trinity College-Hartford and a master’s certification in Education from Saint Joseph College.
Throughout her career, Christian’s expertise has been sought in support of M&A activities. After having helped grow a company’s book of business 3x, she joined a small confidential leadership team to complete due diligence and support what was ultimately an $80M acquisition. At another engagement, Christian managed over $250M in net-based assets YOY through strategic partnerships with a portfolio value of over $750M annually.
Vice President, Global Strategy
With more than twenty years of experience in clinical research monitoring and management, Ghiorghis Belai serves as FHI Clinical’s Vice President, Global Strategy. In this role, Belai is responsible for managing FHI Clinical’s relationships with sponsors and sites, and he works on project feasibility to ensure optimal implementation of trials.
Belai previously served as Director of Clinical Operations for FHI 360, where he managed the clinical research unit based in Nairobi, Kenya, while supervising and mentoring the FHI 360 Africa Regional Clinical Research Unit. In this role, Belai was responsible for reviewing study protocols, coordinating study implementation of multi-center and multi-country trials in Africa, and ensuring that studies adhered to protocol requirements and applicable regulations and guidelines.
With a background in clinical research, Belai has also worked as a clinical research associate for PharmaNet Development Group, Inc., and PPD, where he participated in multiple multi-center clinical research studies, assisted with project data clinical review and management, and presented at investigator meetings for assigned studies. In addition, Belai monitored sites according to applicable standard operating procedures and Food and Drug Administration guidelines and reviewed case report forms for adherence to protocol requirements.
Belai holds a bachelor’s degree in Clinical Laboratory Science from the University of Louisiana at Monroe and a master’s degree in Clinical Research from the University of Liverpool.
As Vice President, Business Development, Jeff Cazeault leads the business development team in driving the expansion of the FHI Clinical’s global sales strategy and portfolio in infectious disease. With a background in global team development and management, strategic partnerships and sales strategy, Cazeault has provided disruptive growth and development in pharmaceutical, biotech, clinical research, healthcare tech, CI/market research and innovative healthcare start-ups for more than 20 years. Cazeault also has extensive experience in the China pharmaceutical market in working with biotech companies in licensing and business development strategy.
Most recently, Cazeault worked as a business development consultant serving biotech clients that included healthcare firms focusing on orphan and rare diseases and healthcare areas of unmet need. Prior to that, Cazeault was Vice President of Business Development at Atlantic Research Group, Inc and his experience also included serving as Head of Global Sales at Eli Global and in various sales leadership roles at Bristol-Myers Squibb Immunology and Boehringer Ingelheim Pharmaceutical.
Cazeault holds a Bachelor’s degree in Psychology from Virginia Wesleyan College and lives with his wife and four children in Wrightsville Beach, NC.